Merck
American pharmaceutical company
Based in DC
🤖
AI Overview
With $600K in lobbying spend across 13 quarterly filings, Merck is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2019 to 2021.
$600K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $200K |
| 2020 | $200K |
| 2021 | $200K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Consumer Issues, Pharmacy, Health Issues, Budget/Appropriations and 1 more
- •Issues related to Rx Drug Pricing; Issues related to 340b; Issues related to vaccines; Issues related to animal health.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.